🔗 Share this article TikTok Content Creators Driving Unofficial Trade for Unapproved Slimming Drug An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings. Experimental Drug Gaining Popularity Via Social Media The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers. Active Commerce on Social Networks Separately, a flourishing market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the substance there before directing buyers to WhatsApp for purchases. Learning About The Experimental Drug Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic. Healthcare Professionals Express Worries Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of uncertain source. Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro. Legal Status and Implementation Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012. Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or prison. Platform Reaction and Material Removal According to TikTok, the service has removed violative material and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies. Digital Trading Activities Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home. Within moments of entering one group, a seller posted contact information, where most transactions take place. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience. Item Details and Costs Within these communities, posts show dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”. Service Moderation and Security Actions A spokesperson for Telegram said it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Expert Cautions “Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained. Her staff has already seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.” Manufacturer Statement A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly significant medical dangers”.